Please login to the form below
Aimvog
This page shows the latest Aimvog news and features for those working in and with pharma, biotech and healthcare.
CGRP migraine drugs need prior approval for use, recommends ICER
Suggests clinicians should confirm that patients have tried other therapies prior to using CGRP inhibitors
Latest news
-
Novartis, Amgen set low price for first CGRP migraine drug
Aimovig has a list price of $6,900 per year
-
Allergan’s oral migraine drug closer to US filing
New data keeps Allergan ahead of rival Biohaven
More from news
Approximately 3 fully matching, plus 0 partially matching documents found.
Featured jobs
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Manager – Healthcare advertising
-
Salary TBC
Subscribe to our email news alerts
PMHub
AMICULUM Limited
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...
Latest intelligence
- Article: Like, Like, Like: Harnessing the power of social media insights
- ...
- Its Know Your Numbers week
- Do you know yours?...
- What is changing in mental health and dementia care?
- Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...
Quick links
Infographics
